resistell
Resistell is a antibiotic resistance test.
resistell has raised €12M across 2 funding rounds from 6 investors, most recently a Series B round in Dec 2022. Based in Basel, Switzerland; founded 2018; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€12M
€11,852,638
Funding rounds
2
Investors
6
distinct backers
Active since
2019-10
latest 2022-12
Funding by year
EUR raised per yearresistell — funding by year — interactive chart.
Data table
| resistell — funding by year | |
|---|---|
| 2019 | €3.2M |
| 2022 | €8.6M |
Signals
High confidenceRaise-next likelihood10
base rate 48% for Series B
- ▼ Past typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood9
base rate 11% (2+ rounds)
- ▲ 8y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-12-20 | Series B | €8.6M | Launchpad Capital,EIC Fund,OCCIDENT,Private Investors,Trumpf Venture,Zürcher Kantonalbank | View deal → |
| 2019-10-01 | Series A | €3.2M | OCCIDENT | View deal → |
Investors
6Related news
- Resistell raises CHF8.5 million to bring its first product to the marketstartupticker.ch · 2022-12
- startupticker.ch
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData